FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

426130006: Haemophilus b polysaccharide 10micrograms/tetanus toxoid 30micrograms powder for injection solution vial + diluent (product)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    2663063011 Haemophilus b polysaccharide 10micrograms/tetanus toxoid 30micrograms powder for injection solution vial + diluent (product) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT core
    2675078015 Haemophilus b polysaccharide 10micrograms/tetanus toxoid 30micrograms powder for injection solution vial + diluent en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT core
    4712751000005118 Haemophilus influenzae type b-polysaccharidvaccine 10 µg + tetanustoxoid 30 µg pulver til injektionsvæske, opløsning, hætteglas + solvens da Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) Danish module (core metadata concept)

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Haemophilus influenzae type b-polysaccharidvaccine 10 µg + tetanustoxoid 30 µg pulver til injektionsvæske, opløsning, hætteglas + solvens Is a Haemophilus influenzae type B- + tetanusvaccine false Inferred relationship Some
    Haemophilus influenzae type b-polysaccharidvaccine 10 µg + tetanustoxoid 30 µg pulver til injektionsvæske, opløsning, hætteglas + solvens The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. tetanustoxoid false Inferred relationship Some
    Haemophilus influenzae type b-polysaccharidvaccine 10 µg + tetanustoxoid 30 µg pulver til injektionsvæske, opløsning, hætteglas + solvens The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. vaccine mod Haemophilus influenzae type B false Inferred relationship Some
    Haemophilus influenzae type b-polysaccharidvaccine 10 µg + tetanustoxoid 30 µg pulver til injektionsvæske, opløsning, hætteglas + solvens The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. tetanusvaccine false Inferred relationship Some
    Inbound Relationships Type Active Source Characteristic Refinability Group

    Reference Sets

    Concept inactivation indicator reference set

    POSSIBLY EQUIVALENT TO association reference set (foundation metadata concept)

    Back to Start